Literature DB >> 17703421

Coinfection and superinfection in patients with long-term, nonprogressive HIV-1 disease.

Concepción Casado1, Maria Pernas, Tamara Alvaro, Virginia Sandonis, Soledad García, Carmen Rodríguez, Jorge del Romero, Eulalia Grau, Lidia Ruiz, Cecilio Lopez-Galindez.   

Abstract

Human immunodeficiency virus 1 (HIV-1) dual infections are considered important because they have been related to AIDS progression. We identified dual infections in 2 patients with long-term, nonprogressive HIV-1 disease; the first patient was diagnosed as being already coinfected, on the basis of the first sample analyzed, but a previous superinfection could not be excluded; the second patient was diagnosed as having a superinfection, on the basis of the 9-year difference between the viral dating of the 2 strains. Dual infections occur in patients with long-term, nonprogressive disease, with no immediate clinical manifestations. Such occurrences could indicate a general phenomenon in natural HIV-1 infections.

Entities:  

Mesh:

Year:  2007        PMID: 17703421     DOI: 10.1086/520885

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Vital role for CD8+ cells in controlling retroviral infections.

Authors:  Melissa Kane; Laure K Case; Tatyana V Golovkina
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

2.  SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?

Authors:  Robert Sealy; Xiaoyan Zhan; Timothy D Lockey; Louis Martin; James Blanchard; Vicki Traina-Dorge; Julia L Hurwitz
Journal:  Curr HIV Res       Date:  2009-09       Impact factor: 1.581

3.  Latent coinfection and the maintenance of strain diversity.

Authors:  Caroline Colijn; Ted Cohen; Megan Murray
Journal:  Bull Math Biol       Date:  2008-12-10       Impact factor: 1.758

4.  Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.

Authors:  Wendy W Yeh; Pimkwan Jaru-Ampornpan; Daiva Nevidomskyte; Mohammed Asmal; Srinivas S Rao; Adam P Buzby; David C Montefiori; Bette T Korber; Norman L Letvin
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

Review 5.  HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen.

Authors:  Sherri L Surman; Robert Sealy; Bart G Jones; Julia L Hurwitz
Journal:  Hum Vaccin       Date:  2009-04

Review 6.  Frequency and implications of HIV superinfection.

Authors:  Andrew D Redd; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Infect Dis       Date:  2013-05-31       Impact factor: 25.071

7.  Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda.

Authors:  Deogratius Ssemwanga; Frederick Lyagoba; Nicaise Ndembi; Billy N Mayanja; Natasha Larke; Shuyi Wang; Joshua Baalwa; Carolyn Williamson; Heiner Grosskurth; Pontiano Kaleebu
Journal:  Virology       Date:  2011-01-15       Impact factor: 3.616

8.  Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller.

Authors:  María Pernas; Concepción Casado; Carolina Arcones; Anuska Llano; Víctor Sánchez-Merino; Beatriz Mothe; José L Vicario; Eulalia Grau; Lidia Ruiz; Jorge Sánchez; Amalio Telenti; Eloísa Yuste; Christian Brander; Cecilio López- Galíndez
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

9.  HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies.

Authors:  Ireen E Kiwelu; Vladimir Novitsky; Lauren Margolin; Jeannie Baca; Rachel Manongi; Noel Sam; John Shao; Mary F McLane; Saidi H Kapiga; M Essex
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

Review 10.  Identifying HIV-1 dual infections.

Authors:  Antoinette C van der Kuyl; Marion Cornelissen
Journal:  Retrovirology       Date:  2007-09-24       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.